Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001298261 | SCV001487308 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-02-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with AIRE-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with glutamic acid at codon 243 of the AIRE protein (p.Lys243Glu). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamic acid. |
Natera, |
RCV001298261 | SCV002083871 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-07-07 | no assertion criteria provided | clinical testing |